These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2496446)
1. The effect of gabexate mesilate on the outcome of acute hemorrhagic pancreatitis in pigs. Ristkari SK; Rämö OJ; Kiviniemi H; Gröhn P; Mahlberg K; Mokka RE Res Exp Med (Berl); 1989; 189(1):1-8. PubMed ID: 2496446 [TBL] [Abstract][Full Text] [Related]
2. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept]. Kahle M; Klein U; König W; Martin U; Alles JU Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346 [TBL] [Abstract][Full Text] [Related]
3. Synthetic antiproteases in acute pancreatitis: an experimental study. Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237 [TBL] [Abstract][Full Text] [Related]
4. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Freise J; Schmidt FW; Magerstedt P; Schmid K Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725 [TBL] [Abstract][Full Text] [Related]
5. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis. Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022 [TBL] [Abstract][Full Text] [Related]
6. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients]. Freise J; Melzer P; Schmidt FW; Horbach L Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate]. Freise J Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089 [TBL] [Abstract][Full Text] [Related]
8. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2. Hesse B; Lankisch PG; Kunze H Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363 [TBL] [Abstract][Full Text] [Related]
9. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis]. Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate. Schädlich HR; Büchler M; Beger HG Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376 [TBL] [Abstract][Full Text] [Related]
11. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis. Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521 [TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine. Freise J; Wittenberg H; Magerstedt P Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043 [TBL] [Abstract][Full Text] [Related]
13. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis. Kahle M; König H; Filler RD Klin Wochenschr; 1989 Feb; 67(3):177-9. PubMed ID: 2494378 [TBL] [Abstract][Full Text] [Related]
15. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Caronna R; Diana L; Nofroni I; Sibio S; Catinelli S; Sammartino P; Chirletti P Dig Dis Sci; 2005 May; 50(5):868-73. PubMed ID: 15906759 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Niederau C; Crass RA; Silver G; Ferrell LD; Grendell JH Gastroenterology; 1988 Dec; 95(6):1648-57. PubMed ID: 3141239 [TBL] [Abstract][Full Text] [Related]
17. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study. Gao HJ; Song Q; Lv FQ; Wang S; Wang YR; Luo YK; Mei XG; Tang J J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):707-711. PubMed ID: 26489626 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes. Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis. Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771 [TBL] [Abstract][Full Text] [Related]
20. Toxic products in hemorrhagic ascitic fluid generated during experimental acute hemorrhagic pancreatitis in dogs and a treatment which reduces their effect. Satake K; Koh I; Nishiwaki H; Umeyama K Digestion; 1985; 32(2):99-105. PubMed ID: 4043568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]